Does the Senate vote on stem-cell research matter?
By Richard Hayes,
San Francisco Chronicle
| 07. 19. 2006
YES: It's a step toward needed oversight and regulation
After years of rancorous debate, Tuesday's vote by the U.S. Senate on a package of stem-cell research bills suggests that responsible bipartisan action actually may be possible.
Nineteen Republican senators broke with the anti-abortion base of their party and with President Bush, by voting to lift the restrictions imposed five years ago by the president on federal funding for stem-cell research.
On the other side of the aisle, pro-choice Democrats voted to support a companion bill banning the intentional creation and abortion of fetuses in order to use their tissues for experimental purposes. Although no one, as far as anyone knows, has proposed doing this at this time, the vote affirms that liberals and conservatives can agree that some forms of biomedical research are ethically unacceptable and should be prohibited.
Also encouraging was what was left out of the package, notably, any move to authorize federal funding for research cloning, a procedure fraught with risks. At one time, cloning was thought to be necessary for stem-cell therapy to work, but many scientists increasingly believe that this is not the case...
Related Articles
By Risa Cromer, The Conversation | 07.17.2026
By Emily Packard Dawson and Lainie Friedman Ross , The Hastings Center for Bioethics | 07.16.2026
Major news outlets recently reported – based on a bioRxiv preprint – that scientists had edited genes in human embryos with “startling precision.” The scientists’ decision to release this work ahead of peer review, coupled with the extensive media coverage...
By Julia Métraux, Mother Jones [cites CGS' Katie Hasson] | 07.07.2026
During his 2015 State of the Union address, then-President Barack Obama announced what he promised would be an ambitious public health project. “Tonight, I’m launching a new Precision Medicine Initiative to bring us closer to curing diseases like cancer and diabetes...
By Emily Baumgaertner Nunn, The New York Times | 06.30.2026
A research program at the National Institutes of Health released the world’s largest database of human genomes and paired them with clinical data, officials announced Tuesday, paving the way for a new era of study in personalized medicine.
The All...